Coverage with Evidence Development Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease (AD) |
Centers for Medicare & Medicaid Services (CMS) has sent this update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page. |
|